(ICAD) |
| 0 (0%) 05-29 15:06 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Wed, 27 May 2026
ICAD II, Abu Dhabi Industrial City, Abu Dhabi Emirate - MSN
Tue, 31 Mar 2026
MicroPort NeuroScientific granted US FDA breakthrough designation for Apollo Dream stent system - NeuroNews International
Tue, 24 Mar 2026
ICAD Names New Leadership for 2026 - Little Black Book | LBBOnline
Mon, 16 Feb 2026
Beyond Swarming: Documenting Harassment, Assault, and ICAD by Chinese Maritime Militia - Small Wars Journal
Tue, 20 Jan 2026
New angioplasty technique shows promise in ICAD patients - AuntMinnie
Thu, 20 Nov 2025
Comparative safety of stent retriever designs for intracranial atherosclerotic disease related large vessel occlusion using agarose models - Nature
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
